Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRII-296 in Severe Postpartum Depression
NCT06057012Phase 2Completed
- Sponsor
- Brii Biosciences
- Start
- Sep 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BRII-296 in postpartum depression (PPD), sponsored by Brii Biosciences. Started Sep 2023; status: completed.
02
Drugs
BRII-296
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT06057012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06057012.